vs
KKR Real Estate Finance Trust Inc.（KREF）与LIFECORE BIOMEDICAL, INC. \DE\（LFCR）财务数据对比。点击上方公司名可切换其他公司
LIFECORE BIOMEDICAL, INC. \DE\的季度营收约是KKR Real Estate Finance Trust Inc.的1.2倍（$31.1M vs $25.8M），LIFECORE BIOMEDICAL, INC. \DE\净利率更高（-32.1% vs -101.7%，领先69.6%），LIFECORE BIOMEDICAL, INC. \DE\同比增速更快（-4.5% vs -26.6%），过去两年LIFECORE BIOMEDICAL, INC. \DE\的营收复合增速更高（-0.1% vs -18.8%）
KKR房地产金融信托公司是全球投资机构KKR旗下的专业房地产金融平台，主要发起、收购并管理优先担保商业地产贷款组合，抵押物多为美国各地的优质机构级商业地产，通过贷款利息收入为投资者提供稳定的经风险调整后的回报。
LIFECORE BIOMEDICAL, INC.是一家生物医药企业，专注于研发和生产以透明质酸为主的高品质生物材料，业务覆盖医疗应用产品、制药解决方案、个人护理原料三大核心板块，主要市场遍布北美、欧洲、亚太地区，服务头部医疗器械、制药、美妆品牌客户。
KREF vs LFCR — 直观对比
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $25.8M | $31.1M |
| 净利润 | $-26.2M | $-10.0M |
| 毛利率 | — | 25.0% |
| 营业利润率 | -105.1% | -9.9% |
| 净利率 | -101.7% | -32.1% |
| 营收同比 | -26.6% | -4.5% |
| 净利润同比 | -229.6% | -52.0% |
| 每股收益（稀释后） | $-0.49 | $-0.29 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $25.8M | — | ||
| Q3 25 | $25.3M | $31.1M | ||
| Q2 25 | $30.2M | — | ||
| Q1 25 | $31.3M | $35.2M | ||
| Q4 24 | $35.1M | $32.6M | ||
| Q3 24 | $37.0M | $24.7M | ||
| Q2 24 | $40.4M | — | ||
| Q1 24 | $39.1M | $35.7M |
| Q4 25 | $-26.2M | — | ||
| Q3 25 | $13.8M | $-10.0M | ||
| Q2 25 | $-29.7M | — | ||
| Q1 25 | $-4.9M | $-14.8M | ||
| Q4 24 | $20.3M | $-6.6M | ||
| Q3 24 | $-7.4M | $-16.2M | ||
| Q2 24 | $25.8M | — | ||
| Q1 24 | $-3.1M | $15.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | 25.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 33.3% |
| Q4 25 | -105.1% | — | ||
| Q3 25 | 50.4% | -9.9% | ||
| Q2 25 | -101.3% | — | ||
| Q1 25 | -18.3% | -25.7% | ||
| Q4 24 | 55.8% | -6.0% | ||
| Q3 24 | -19.6% | -46.9% | ||
| Q2 24 | 63.3% | — | ||
| Q1 24 | -8.7% | -2.5% |
| Q4 25 | -101.7% | — | ||
| Q3 25 | 54.4% | -32.1% | ||
| Q2 25 | -98.5% | — | ||
| Q1 25 | -15.5% | -42.0% | ||
| Q4 24 | 57.7% | -20.2% | ||
| Q3 24 | -20.0% | -65.7% | ||
| Q2 24 | 63.9% | — | ||
| Q1 24 | -7.9% | 43.8% |
| Q4 25 | $-0.49 | — | ||
| Q3 25 | $0.12 | $-0.29 | ||
| Q2 25 | $-0.53 | — | ||
| Q1 25 | $-0.15 | $-0.47 | ||
| Q4 24 | $0.22 | $-0.25 | ||
| Q3 24 | $-0.19 | $-0.53 | ||
| Q2 24 | $0.29 | — | ||
| Q1 24 | $-0.13 | $0.42 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $84.6M | $18.9M |
| 总债务越低越好 | — | $136.0M |
| 股东权益账面价值 | $1.2B | $-10.5M |
| 总资产 | $6.5B | $235.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $84.6M | — | ||
| Q3 25 | $204.1M | $18.9M | ||
| Q2 25 | $107.7M | — | ||
| Q1 25 | $106.4M | $5.4M | ||
| Q4 24 | $104.9M | $9.5M | ||
| Q3 24 | $108.8M | — | ||
| Q2 24 | $107.2M | — | ||
| Q1 24 | $106.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $136.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $111.3M | ||
| Q3 24 | — | $106.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $97.1M |
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | $-10.5M | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.3B | $2.2M | ||
| Q4 24 | $1.3B | $15.4M | ||
| Q3 24 | $1.4B | $-3.9M | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $1.4B | $17.7M |
| Q4 25 | $6.5B | — | ||
| Q3 25 | $6.5B | $235.2M | ||
| Q2 25 | $6.8B | — | ||
| Q1 25 | $6.6B | $237.7M | ||
| Q4 24 | $6.4B | $255.4M | ||
| Q3 24 | $6.8B | $246.8M | ||
| Q2 24 | $7.1B | — | ||
| Q1 24 | $7.3B | $246.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 56.05× | ||
| Q4 24 | — | 7.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.49× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $72.3M | $1.8M |
| 自由现金流经营现金流 - 资本支出 | — | $25.0K |
| 自由现金流率自由现金流/营收 | — | 0.1% |
| 资本支出强度资本支出/营收 | — | 5.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-16.8M |
8季度趋势，按日历期对齐
| Q4 25 | $72.3M | — | ||
| Q3 25 | $18.5M | $1.8M | ||
| Q2 25 | $21.1M | — | ||
| Q1 25 | $15.9M | $1.2M | ||
| Q4 24 | $132.6M | $-6.1M | ||
| Q3 24 | $49.1M | $-613.0K | ||
| Q2 24 | $30.6M | — | ||
| Q1 24 | $34.5M | $-1.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | $25.0K | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-4.3M | ||
| Q4 24 | — | $-8.6M | ||
| Q3 24 | — | $-4.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-7.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -12.1% | ||
| Q4 24 | — | -26.3% | ||
| Q3 24 | — | -16.3% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -21.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | 5.6% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 15.5% | ||
| Q4 24 | — | 7.5% | ||
| Q3 24 | — | 13.9% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 17.8% |
| Q4 25 | — | — | ||
| Q3 25 | 1.34× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.54× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.19× | — | ||
| Q1 24 | — | -0.09× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KREF
暂无分部数据
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
